Literature DB >> 1081990

Lipid A, the active part of bacterial endotoxins in inducing serum colony stimulating activity and proliferation of splenic granulocyte/macrophage progenitor cells.

R N Apte, C Galanos, D H Pluznik.   

Abstract

An analysis of which component of lipopolysaccharides (LPS), the lipid or the polysaccharide (PS), is active in stimulating the murine granulopoietic system has been performed. LPS with different structures, isolated from different mutant strains of Salmonella and chemical degradation products of lipopolysaccharides have been used. Lipid A obtained by acid hydrolysys of the LPS and complexed to bovine serum albumin (BSA) (lipid A-BSA) was shown to be active in generating serum colony stimulating factor (CSF) and in increasing the splenic colony forming cells (CFC) levels, although it was less active than the parent LPS. The polysaccharide (PS) showed no significant activity at the concentrations used. LPS (glycolipids) from R mutants of Salmonella minnesota were active to the same extent as the LPS. The fact that even the most defective LPS from the R mutant R595 which contains lipid A and KDO only is a potent endotoxin, points unequivocally, to lipid A, as the active principle in stimulating the granulopoietic system.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1081990     DOI: 10.1002/jcp.1040870110

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  17 in total

Review 1.  Use of immune modulators in nonspecific therapy of bacterial infections.

Authors:  M T Vogels; J W van der Meer
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  Myelopoiesis in experimentally contaminated specific-pathogen-free and germfree mice during oral administration of polymyxin.

Authors:  H Goris; F de Boer; D van der Waaij
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

3.  Immunopharmacological activities of 2-keto-3-deoxyoctonic acid-(alpha 2----6)-linked 4-O-phosphono-D-glucosamine derivatives carrying N- and 3-O-acyl substituents.

Authors:  Y Kumazawa; M Matsuura; J Y Homma; T Furuya; H Takimoto; K Inagaki; T Nagumo; M Kiso; A Hasegawa
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

4.  Immunomodulatory activity of monophosphoryl lipid A in C3H/HeJ and C3H/HeSnJ mice.

Authors:  J R Hiernaux; P W Stashak; J L Cantrell; J A Rudbach; P J Baker
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

5.  Induction of early-phase endotoxin tolerance in athymic (nude) mice, B-cell-deficient (xid) mice, and splenectomized mice.

Authors:  G S Madonna; S N Vogel
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

Review 6.  The effects of bacterial endotoxins on host mediation systems. A review.

Authors:  D C Morrison; R J Ulevitch
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

7.  Modulations of myelopoiesis in vivo by chemically pure preparations of cell wall components from gram-negative bacteria: effects at different stages.

Authors:  F G Staber; L Tarcsay; P Dukor
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

8.  Interaction between endotoxin and human monocytes: characteristics of the binding of 3H-labeled lipopolysaccharide and 51Cr-labeled lipid A before and after the induction of endotoxin tolerance.

Authors:  N E Larsen; R Sullivan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Use of mice tolerant to lipopolysaccharide to demonstrate requirement of cooperation between macrophages and lymphocytes to generate lipopolysaccharide-induced colony-stimulating factor in vivo.

Authors:  Z Williams; C F Hertogs; D H Pluznik
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

10.  Endotoxin-associated protein: a potent stimulus for human granulocytopoietic activity which may be accessory cell independent.

Authors:  B H Bjornson; E Agura; J M Harvey; M Johns; R G Andrews; W R McCabe
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.